The rapid test reacts to the presence of antibodies against the S-protein and the N-protein, which are formed in the event of a successful vaccination with an approved vaccine or a survived SARS-CoV-2 infection.
In addition to the test that is already available, it is now also possible to detect antibodies after vaccination.
The test detects antibodies against the S1 receptor binding domain, which are formed after vaccination with the mRNA vaccines currently approved in the EU.
Result after approx. 15 minutes.